MarketsandMarkets: Global Oncology Biomarkers Market Worth US$9.5 billion by 2014
The key factors driving the growth of the overall oncology biomarkers market include the rising prevalence of cancer across the globe; and the early diagnosis and enhanced testing capabilities biomarkers facilitate. Further, U.S. government initiatives and increasing patient awareness are also enhancing market growth.
View full press release